LIXT Stock, Lixte Biotechnology Holdings Inc. Information
Stock Information
Get LIXT Alerts
News, Short Squeeze, Breakout and More Instantly...
About Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings, Inc. is a clinical stage public pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. Lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. The current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.